香港股市 已收市

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
223.32+0.84 (+0.38%)
收市:04:00PM EST
223.25 -0.07 (-0.03%)
收市後: 08:00PM EST
全螢幕
交易股價資料並非來自所有市場
前收市價222.48
開市223.43
買盤218.00 x 900
賣出價223.50 x 800
今日波幅221.50 - 225.80
52 週波幅215.68 - 319.76
成交量900,915
平均成交量1,134,486
市值32.462B
Beta 值 (5 年,每月)0.00
市盈率 (最近 12 個月)28.02
每股盈利 (最近 12 個月)7.97
業績公佈日2024年4月23日 - 2024年4月29日
遠期股息及收益率無 (無)
除息日
1 年預測目標價306.07
  • Investor's Business Daily

    Is Eli Lilly Stock A Buy As Amgen Enters The Red-Hot Weight-Loss Ring?

    There's a growing field of competitors in the weight-loss drugs space, where Lilly and Novo currently dominate. Is Eli Lilly stock a buy?

  • Reuters

    UPDATE 2-EU medicines regulator backs Biogen's ALS drug

    Europe's medicines regulator on Friday recommended granting a marketing authorization to Biogen's drug for the deadly and progressive neurodegenerative disease known as amyotrophic lateral sclerosis (ALS). The drug, Qalsody, received accelerated approved in the United States in April last year, based on preliminary data that showed it reduced levels of a neurofilament protein that scientists believe is tied with progression of the disease. ALS is a rare neurological disease that can affect nerve cells in the brain and spinal cord responsible for muscle movements, leading to progressive paralysis and death.

  • Insider Monkey

    20 Most Sustainable Companies in the US

    In this article, we will look into the 20 most sustainable companies in the US. If you want to skip our detailed analysis, you can go directly to the 5 Most Sustainable Companies in the US. Sustainability Outlook for the US According to the SDSN Sustainable Development Report 2023, the United States demonstrates mixed performance […]